Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06172842

Multi-modality Echocardiography for Cardiac Assessment in Primary Electrical Disease

Status
Recruiting
Phase
Study type
Observational
Enrollment
30 (estimated)
Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

From 2020 to 2023, patients with primary electrical disease (idiopathic ventricular fibrillation, long QT syndrome, Andersen-Tawil syndrome type I, Brugada syndrome, early repolarization syndrome, CPVT, and short QT syndrome) were first diagnosed at Sun Yat-sen Memorial Hospital of Sun Yat-sen University, and clinical data and echocardiographic indicators were recorded. Follow-up is until December 30, 2025 or endpoint event occurs. Endpoint events were defined as sustained ventricular tachycardia, ventricular fibrillation, sudden cardiac death, ICD discharge events, all-cause death, heart failure and heart transplantation, which were statistically analyzed as a composite endpoint of cardiovascular analysis. The predictors of primary electrical disease and the risk factors for adverse cardiovascular events were analyzed.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTEchocardiographyMulti-modality echocardiography

Timeline

Start date
2024-01-01
Primary completion
2025-12-01
Completion
2026-10-01
First posted
2023-12-15
Last updated
2024-01-23

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06172842. Inclusion in this directory is not an endorsement.